OTCMKTS:CBNT

C-Bond Systems (CBNT) Stock Price, News & Analysis

$0.0040
0.00 (0.00%)
(As of 05/17/2024 ET)
Today's Range
$0.0037
$0.0040
50-Day Range
N/A
52-Week Range
$0.0030
$0.0150
Volume
8,300 shs
Average Volume
278,049 shs
Market Capitalization
$2.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CBNT stock logo

About C-Bond Systems Stock (OTCMKTS:CBNT)

C-Bond Systems, Inc., a nanotechnology company, owns, develops, manufactures, and sells patented C-Bond technology in the United Sates. The company's products include C-Bond NanoShield, a patented nanotechnology windshield glass strengthening and hydrophobic performance system to enhance windshield safety and performance; C-Bond Secure, a patented non-toxic water-based nanotechnology solution to increase the strength of architectural glass and performance properties of window film-to-glass products; and C-Bond BRS, a patented nanotechnology ballistic-resistant film system that increases the structural integrity of glass. It also distributes MB-10 and Vimoba disinfectant tablets to Automotive, Trucking, RV, rental agencies, service vehicles, mass transit, golf carts, aviation, train, and marine markets, as well as to transportation dealerships, and service providers. The company was founded in 2013 and is headquartered in Houston, Texas.

CBNT Stock Price History

CBNT Stock News Headlines

C-Bond Systems Inc.
C-Bond Systems reports record revenue
See More Headlines
Receive CBNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for C-Bond Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/19/2021
Today
5/18/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Investors, not elsewhere classified
Sub-Industry
N/A
Current Symbol
OTCMKTS:CBNT
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Net Income
$1.90 million
Pretax Margin
79.11%

Debt

Sales & Book Value

Annual Sales
$2.49 million
Cash Flow
$0.00 per share
Book Value
($0.01) per share

Miscellaneous

Free Float
423,577,000
Market Cap
$2.18 million
Optionable
Not Optionable
Beta
0.68
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Scott R. Silverman (Age 60)
    CEO, Interim CFO, Treasurer & Chairman of the Board
    Comp: $823.66k
  • Ms. Allison F. Tomek (Age 47)
    President, VP of Corporate Communication, Secretary & Director
    Comp: $374.62k
  • Dr. Andrew R. Barron
    Chief Technology Officer
  • Dr. Enrique Barrera
    Chief Science Advisor
  • Mr. Brian P. Fenske J.D.
    Legal Counsel & Member of Advisory Board
  • Mr. Craig Steinroeder
    Vice President of Sales & Business Development
  • Mr. Michael Wanke (Age 60)
    President of Patriot Glass Solutions

CBNT Stock Analysis - Frequently Asked Questions

How have CBNT shares performed in 2024?

C-Bond Systems' stock was trading at $0.0055 on January 1st, 2024. Since then, CBNT stock has decreased by 27.3% and is now trading at $0.0040.
View the best growth stocks for 2024 here
.

Are investors shorting C-Bond Systems?

C-Bond Systems saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 100 shares, a decrease of 99.8% from the April 15th total of 62,900 shares. Based on an average daily trading volume, of 518,800 shares, the short-interest ratio is currently 0.0 days.
View C-Bond Systems' Short Interest
.

How were C-Bond Systems' earnings last quarter?

C-Bond Systems, Inc. (OTCMKTS:CBNT) issued its quarterly earnings data on Monday, April, 19th. The company reported ($0.01) earnings per share for the quarter, meeting the consensus estimate of ($0.01). The company had revenue of $0.30 million for the quarter.

What other stocks do shareholders of C-Bond Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other C-Bond Systems investors own include Allena Pharmaceuticals (ALNA), Arbutus Biopharma (ABUS), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Ampliphi Biosciences (APHB), Apellis Pharmaceuticals (APLS), Ardelyx (ARDX), ArQule (ARQL) and Athersys (ATHX).

How do I buy shares of C-Bond Systems?

Shares of CBNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CBNT) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners